Skip to content

Behavioral Nudge in Colorectal Cancer Screening

Role of Behavioral Nudge as a Tool to Increase CRC Screening at an Urban Center Outpatient Clinic

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06796049
Enrollment
0
Registered
2025-01-28
Start date
2025-05-01
Completion date
2026-07-01
Last updated
2026-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improving Fecal Immunochemical Test (FIT) Completion Rates

Brief summary

The purpose of this study is to evaluate if a behavioral nudge principle known as social norm driver can be implemented to improve fecal immunochemical test (FIT) completion rates for patients' age 45-75 years old due for colorectal cancer screening at Bellevue Hospital Medicine Ambulatory Care Clinic. The study's endpoints include FIT screening completion rate and timeliness. Secondary analysis will look at demographic information such as age group, gender, prior screening, number of prior visits at the clinic.

Interventions

BEHAVIORALInformation pamphlet + social norm driver

The information pamphlet is given to participants at the end of the visit. The pamphlet contains an easy-to-read description of FIT screening adapted from the NYC department of health C5 Colorectal cancer (CRC) screening coalition pamphlet and lead-time CRC screening messaging tool, instructions on how to complete the test and the importance of FIT screening. The information pamphlet will also contain a social norm driver that displays the sub-par screening rate the clinic compared to a collective New York State screening rate and a national screening rate goal set by the CDC.

The information pamphlet is given to participants at the end of the visit. The pamphlet contains an easy-to-read description of FIT screening adapted from the NYC department of health C5 CRC screening coalition pamphlet and lead-time CRC screening messaging tool, instructions on how to complete the test and the importance of FIT screening.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

Time Period 1 Inclusion Criteria: 1. Patient at Bellevue Ambulatory Care Medicine Clinic between 1/1/2024 and 7/1/2024 2. Age 45-75 years old Time Period 2 Inclusion Criteria: 1. Patient at Bellevue Ambulatory Care Resident Clinic 2. Age 45-75 years old 3. Has not had a FIT test within the past year 4. Can read either English or Spanish 5. Is able and willing to provide consent Time Period 3 Inclusion Criteria: 1. Patient at Bellevue Ambulatory Care Resident Clinic 2. Age 45-75 years old 3. Has not had a FIT test completed within the past year 4. Can read either English or Spanish 5. Is able and willing to provide consent Time Period 1

Exclusion criteria

1. Patient at a clinic that is not Bellevue Ambulatory Care Resident Clinic 2. Age outside of 45-75 years old Time Period 2

Design outcomes

Primary

MeasureTime frameDescription
Time until the fecal immunochemical test (FIT) is returned to the clinic for processingMonth 3Study participants will be tracked for completion of their FIT screening test up until 3 months after the initial stool study was given.
Percentage of participants who completed the FIT screening testMonth 3Study participants will be tracked for completion of their FIT screening test up until 3 months after the initial stool study was given.

Countries

United States

Contacts

STUDY_DIRECTORAasma Shaukat, MD

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026